Tran AD - Search Results

1

Health utility among people who regularly use opioids in Australia.

Tran AD, Grebely J, Chambers M, Degenhardt L, Farrell M, Bajis S, Larance B. Tran AD, et al. Drug Alcohol Rev. 2024 May;43(4):997-1012. doi: 10.1111/dar.13823. Epub 2024 Feb 25. Drug Alcohol Rev. 2024. PMID: 38403293

2

Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross-sectional survey of Australian treatment clients.

Zahra E, Chen R, Nielsen S, Tran AD, Santo T Jr, Degenhardt L, Farrell M, Byrne J, Ali R, Larance B. Zahra E, et al. Among authors: tran ad. Drug Alcohol Rev. 2022 May;41(4):841-850. doi: 10.1111/dar.13437. Epub 2022 Feb 7. Drug Alcohol Rev. 2022. PMID: 35130368 Free PMC article.

3

Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions.

Tran AD, Chen R, Nielsen S, Zahra E, Degenhardt L, Santo T Jr, Farrell M, Larance B. Tran AD, et al. Int J Drug Policy. 2022 Jan;99:103472. doi: 10.1016/j.drugpo.2021.103472. Epub 2021 Oct 11. Int J Drug Policy. 2022. PMID: 34649203

4

Health utilities among Aboriginal people attending residential rehabilitation services in New South Wales, Australia: An observational follow-up study.

Vinzent A, Fredes-Torres M, Shakeshaft A, Doran CM, Settumba S, Clifford-Motopi A, Tran AD. Vinzent A, et al. Among authors: tran ad. Drug Alcohol Rev. 2023 Feb;42(2):248-257. doi: 10.1111/dar.13586. Epub 2022 Dec 11. Drug Alcohol Rev. 2023. PMID: 36504471

5

Shah KK, Murtagh FEM, McGeechan K, Crail S, Burns A, Tran AD, Morton RL. Shah KK, et al. Among authors: tran ad. BMJ Open. 2019 May 19;9(5):e027776. doi: 10.1136/bmjopen-2018-027776. BMJ Open. 2019. PMID: 31110102 Free PMC article.

6

Cost Analysis of Adjuvant Whole-Brain Radiotherapy Treatment Versus No Whole-Brain Radiotherapy After Stereotactic Radiosurgery and/or Surgery Among Adults with One to Three Melanoma Brain Metastases: Results from a Randomized Trial.

Tran AD, Hong AM, Nguyen MTH, Fogarty G, Steel V, Paton E, Morton RL. Tran AD, et al. Pharmacoecon Open. 2022 Jul;6(4):587-594. doi: 10.1007/s41669-022-00332-8. Epub 2022 May 5. Pharmacoecon Open. 2022. PMID: 35513735 Free PMC article.

7

Systematic Review of the Costs and Benefits of Prescribed Cannabis-Based Medicines for the Management of Chronic Illness: Lessons from Multiple Sclerosis.

Herzog S, Shanahan M, Grimison P, Tran A, Wong N, Lintzeris N, Simes J, Stockler M, Morton RL. Herzog S, et al. Pharmacoeconomics. 2018 Jan;36(1):67-78. doi: 10.1007/s40273-017-0565-6. Pharmacoeconomics. 2018. PMID: 28866778

8

Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.

Dieng M, Kasparian NA, Cust AE, Costa DSJ, Tran A, Butow PN, Menzies SW, Mann GJ, Morton RL. Dieng M, et al. JAMA Dermatol. 2018 Jan 1;154(1):52-59. doi: 10.1001/jamadermatol.2017.4701. JAMA Dermatol. 2018. PMID: 29188268 Free PMC article. Clinical Trial.

9

Quality of Life Following Sentinel Node Biopsy for Primary Cutaneous Melanoma: Health Economic Implications.

Morton RL, Tran A, Vessey JY, Rowbotham N, Winstanley J, Shannon K, Spillane AJ, Stretch J, Thompson JF, Saw RP. Morton RL, et al. Ann Surg Oncol. 2017 Aug;24(8):2071-2079. doi: 10.1245/s10434-017-5842-2. Epub 2017 Mar 20. Ann Surg Oncol. 2017. PMID: 28321690

10

The savings associated with decriminalization of drug use in New South Wales, Australia: A comparison of four drug policies.

Tran AD, Weatherburn D, Poynton S. Tran AD, et al. J Subst Use Addict Treat. 2023 Jun;149:208983. doi: 10.1016/j.josat.2023.208983. Epub 2023 Feb 17. J Subst Use Addict Treat. 2023. PMID: 36934043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page